Alpha Healthcare Acquisition Corp. III (ALPA) Stock Analysis
NASDAQFinancial ServicesShell Companies
What Alpha Healthcare Acquisition Corp. III does
Alpha Healthcare Acquisition Corp. III currently lacks significant operational activities. This New York-based firm, established in 2021, is dedicated to executing a business combination—such as a merger, asset acquisition, stock exchange, or reorganization—with one or more entities. Its strategic focus is on identifying, acquiring, and managing a business within the United States' healthcare industry.
Key metrics
ETFs linked to ALPA
Broad-market and Financial Services sector ETFs an investor holding Alpha Healthcare Acquisition Corp. III is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ALPA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ALPA in PortView →Frequently asked questions
- What is the ticker symbol for Alpha Healthcare Acquisition Corp. III?
- Alpha Healthcare Acquisition Corp. III trades under the ticker ALPA on NASDAQ.
- Which exchange is ALPA listed on?
- ALPA is listed on NASDAQ.
- What sector does Alpha Healthcare Acquisition Corp. III operate in?
- Alpha Healthcare Acquisition Corp. III is classified in the Financial Services sector (Shell Companies industry).
- How can PortView help analyze ALPA in a portfolio?
- PortView shows ALPA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.